GENEVA, 30 August, 2023: The Stop Tb Partnership´s Global Drug Facility (GDF) today announced price reductions up to 55% for bedaquiline, a critical drug used to treat drug-resistant TB (DR-TB)The new, reduced bedquiline prices - secured through an open, competitive tender and valid through…
NEWS ALERT - 15 August 2023 | Geneva, SwitzerlandLaunch of the Six Weeks Campaign toUN High Level Meeting on TB!Join our children and youth in asking for a future without TB! #UNGA78 #2023TBHLM #EndTB #OurFuture 14 August 2023, Geneva,…
Registration Now Open for Accredited Non-State Actors Until 11th AugustDear Partners,With this message we want to share as many details as we can related to participation to the UN on High-Level Meeting (HLM) on TB on 22 September 2023.Please kindly be aware that unless you are part of…
Historic funding available for civil society and communities to champion ambitious people-centered, human-rights based, gender-transformative TB responses Apply now to be part of the USD 13.5 million available for grants from Challenge Facility for Civil Society Round…
13 July 2023 Following lengthy negotiations, Johnson & Johnson has granted Stop TB Partnership´s Global Drug Facility`s licenses that enable Global Drug Facility (GDF) to tender, procure, and supply generic versions of SIRTURO® (bedaquiline) for the majority of low-and middle-income countries,…
14 May 2023 | Geneva, SwitzerlandThe resounding echoes of "YES WE CAN! END TB!" reverberated through the hall as TB stakeholders arrived at the United Nations in New York, wielding an urgent call to action. With unwavering determination and a powerful sense of purpose, they demanded that…